Cardiac autonomic neuropathy: Risk factors, diagnosis and treatment

Authors: Victoria A Serhiyenko, Alexandr A Serhiyenko.

Summary:

Examined how spontaneous hypoglycemia in patients with type 2 diabetes affects cardiac rhythm by comparing arrhythmia frequency, heart rate variability, and repolarization markers during hypoglycemic, hyperglycemic, and euglycemic periods matched by time of day.

Key Findings:

Cardiac Autonomic Neuropathy (CAN) in diabetes is linked to 5 fold increase in cardiovascular mortality

CAN presents as resting sinus tachycardia, fixed heart rate, exercise intolerance, orthostatic hypotension, dizziness/syncope, impaired BP regulation and silent MI

Structured screening plus targeted risk reduction recommended: incorporate ECG, HRV and BP monitoring

The content on iRhythm Academy is provided for general educational purposes only and should not be considered the exclusive source for this type of information. This training does not replace or supersede approved labeling. The content will be shared with physicians and healthcare professionals who seek a deeper understanding of the operation and use of iRhythm products and services with the intent of enhancing their knowledge of features and operations described in the clinician manuals. At all times, it is the professional responsibility of the physicians and healthcare professionals to exercise independent clinical judgment in a particular situation. The device and service functionality and programming described on iRhythm Academy are based on its products and services, and can be referenced in the labeling and reference manuals. This website is intended for healthcare professionals and not intended for patients or consumers.